Oryzon Genomics S.A. (LON:0RDB)
3.115
-0.015 (-0.48%)
Feb 12, 2026, 11:33 AM GMT
Oryzon Genomics Revenue
Oryzon Genomics had revenue of $8.63M USD in the twelve months ending September 30, 2025, down -45.45% year-over-year. In the year 2024, Oryzon Genomics had annual revenue of $7.62M, down -51.43%.
Revenue (ttm)
$8.63M
Revenue Growth
-45.45%
P/S Ratio
32.78
Revenue / Employee
$183.70K
Employees
47
Market Cap
210.54M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.62M | -8.07M | -51.43% |
| Dec 31, 2023 | 15.69M | -1.09M | -6.50% |
| Dec 31, 2022 | 16.78M | 4.70M | 38.97% |
| Dec 31, 2021 | 12.07M | 425.74K | 3.66% |
| Dec 31, 2020 | 11.65M | 112.98K | 0.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Integrated Diagnostics Holdings | 114.96M |
| Optima Health | 113.75M |
| Animalcare Group | 81.07M |
| Tristel | 46.46M |